StoxGud Sign in
40

Epigral Limited

NSE: EPIGRAL · Unclassified

₹913.20-3.26%06 Nov 2026

Ask the data

Instant answers about Epigral Limited — computed from its filings, no language model
Market cap₹3,940 cr
Current price₹913.20
High / Low₹1,698 / ₹810
P/E13.8
P/B1.67
Book value₹548.1
ROE12.0%
ROCE14.7%
Debt / equity0.24
Dividend yield0.47%
EPS (TTM)₹66.04
Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin
FY22FY23FY24FY25FY26
Revenue1,5512,1881,9292,5502,527
EBITDA509689481711567
Operating margin32.9%31.5%24.9%27.9%22.4%
Interest4466735372
Depreciation86109124133168
Profit before tax383522291540342
Tax131169951839
Net profit253353196358332
EPS ₹60.8485.0347.1384.6876.95
Operating cash flow284626398441436
Capex456416398195394
Dividend paid024103218
Total assets—2,4322,7943,1523,505
Equity—1,0691,2541,9052,221

Quarterly performance

last 20 quarters · ₹ crore
showing latest 8 of 20 periods
SEP '21DEC '21MAR '22SEP '22DEC '22MAR '23JUN '23SEP '23DEC '23MAR '24JUN '24SEP '24DEC '24MAR '25JUN '25SEP '25DEC '25MAR '26JUN '26SEP '26
Revenue340422499556538562455478472525651626645628607587597736705746
Operating profit10114117518016715595108123155176178183173163132103169179136
Operating margin29.6%33.5%35.1%32.5%31.0%27.5%20.9%22.6%26.0%29.6%27.1%28.5%28.3%27.6%26.9%22.5%17.2%22.9%25.4%18.2%
Other income2-022-0521222643826-146
Interest101012142119182120141427-01223221116711
Depreciation2222212631303132313033323334424243424344
Profit before tax71109144142114110485674113131124154131107705511113387
Tax2439455037331618253645445044-541815293422
Net profit4770999277773238497786811048716151398110065
EPS ₹11.3116.7823.8522.0418.5818.477.589.1411.8118.6020.6719.5724.2520.1437.2511.879.0718.7623.1215.09
Revenue YoY———63.6%27.4%12.7%—-13.9%-12.3%-6.7%43.2%30.9%36.8%19.6%-6.9%-6.2%-7.5%17.3%16.3%27.0%
Profit YoY———94.8%10.7%-22.6%—-58.5%-36.4%0.7%172.5%113.9%111.1%12.4%87.1%-37.0%-62.3%-6.8%-37.9%27.1%

Earlier results (standalone, Jun '21 – Jun '21)

₹ crore · from BSE, before the NSE XBRL filings begin

Epigral Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Quarters

JUN '21†
Revenue290
Operating profit92
Operating margin31.9%
Other income0
Interest12
Depreciation21
Profit before tax59
Tax22
Net profit37
EPS ₹8.89

Returns & margins

trailing-twelve-month, per quarter
showing latest 8 of 14 periods
JUN '23SEP '23DEC '23MAR '24JUN '24SEP '24DEC '24MAR '25JUN '25SEP '25DEC '25MAR '26JUN '26SEP '26
ROE25.9%19.8%17.3%15.6%20.0%21.0%24.9%18.8%22.7%19.2%16.1%14.9%12.2%12.0%
ROCE25.0%19.4%17.5%16.4%20.0%22.6%25.1%23.8%23.2%19.7%16.3%14.9%15.2%14.7%
Net margin13.1%11.0%9.9%10.2%11.8%12.9%14.2%14.0%17.3%16.3%14.0%13.1%10.3%10.2%
EBITDA margin28.3%25.8%24.4%24.9%26.5%27.8%28.3%27.9%27.8%26.4%23.6%22.4%22.2%21.1%
Debt / equity0.820.860.860.770.770.640.640.310.310.250.250.250.250.24
Interest coverage6.695.124.664.966.396.8710.4611.149.279.116.335.757.609.61
Asset turnover0.870.770.740.690.760.760.820.810.790.760.750.720.750.78

Balance sheet

equity vs borrowings over time · ₹ crore
showing latest 6 of 9 periods
SEP '22MAR '23SEP '23MAR '24SEP '24MAR '25SEP '25MAR '26SEP '26
Share capital424242424243434343
Other equity / reserves8841,0281,0871,2131,3591,8612,0582,1782,322
Total equity9251,0691,1281,2541,4001,9052,1012,2212,365
Borrowings939876969963895585532563565
Current liabilities735648792780848493504710712
Non-current liabilities789715728761731755632573508
Total assets2,4492,4322,6482,7942,9793,1523,2363,5053,585
Property, plant & equipment1,7801,7791,7791,7451,8922,2192,1592,1022,047
Capital work-in-progress8315835348335064309451498
Investments02120212198452329
Inventories266212197263337388344349365
Receivables216166191179252232227417396
Cash & equivalents2214832191551

Cash flow

annual · ₹ crore · line = free cash flow
FY22FY23FY24FY25FY26
Cash from operations284626398441436
Cash from investing-455-437-401-262-355
Cash from financing195-200-8-164-94
Capex456416398195394
Free cash flow-172210-124641
Dividends paid024103218

Where the assets sit

Sep '26 · ₹ crore
Fixed assets (PPE)
₹2,047 cr57%
CWIP
₹498 cr14%
Investments
₹29 cr1%
Inventories
₹365 cr10%
Receivables
₹396 cr11%
Cash & equivalents
₹1 cr0%
Other assets
₹249 cr7%

Peer comparison

largest in Unclassified · this company in bold
CompanyMarket cap ₹crPriceP/EP/BROE
Avantel Limited36,86,04,549138.69—1059360.680.0%
Ducol Organics And Colours Limited19,55,275120.00—20089.130.0%
Jio Platforms Limited12,57,1811,406.40—3.57—
SBI Funds Management Limited1,01,750499.55———
Tamilnadu Telecommunication Limited91,3149.93———
Manipal Health Enterprises Limited76,294646.70———
INDO-MIM Limited59,0421,219.50———
AvenuesAI Limited45,138129.25153.69.516.2%
Dhoot Transmission Limited32,7611,601.60—8.11—
3M India Limited31,07127,570.0053.817.5732.7%
Epigral Limited3,940913.2013.81.6712.0%

StoxGud checklist: Neutral setup · 4/10

  • Price above 50-day average
  • Price above 200-day average
  • 50-day average above 200-day (uptrend)
  • RSI in healthy 40–70 zone
  • Positive 1-year return
  • Return on equity above 15%
  • Debt to equity below 1
  • Revenue growing year on year
  • Net profit margin above 10%
  • P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-11.3%
6 months-33.3%
1 year-46.5%
3Y CAGR-0.6%
5Y CAGR+3.1%
10Y CAGR—
50-day avg₹1,047.62
200-day avg₹1,070.49
RSI (14)38

FAQs

What is the share price of Epigral Limited?

Epigral Limited (EPIGRAL) closed at ₹913.20 on NSE on 06 Nov 2026.

What is the market cap of Epigral Limited?

₹3,940 crore at the latest close.

What is the P/E ratio of Epigral Limited?

13.8, on trailing-twelve-month earnings from its filings.

How fast is Epigral Limited growing?

Epigral Limited: revenue has compounded at 4.9% a year over three years; net profit at -2.1% a year. Latest-quarter revenue is up 27.0% year on year, profit up 27.1%.

How profitable is Epigral Limited?

On a trailing-twelve-month basis return on equity is 12.0%, return on capital employed 14.7%, operating margin 21.1%, net margin 10.2%.

How much debt does Epigral Limited have?

Epigral Limited is lightly geared: debt to equity is 0.24 with borrowings of ₹565 cr against cash of ₹1 cr (balance sheet of 2026-09-30). Operating profit covers interest 9.6 times.

Financials parsed from Epigral Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from SEP '21, annual from FY22, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.